Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2025-12-25 @ 11:15 PM
Study NCT ID:
NCT07244393
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-24
First Post:
2025-11-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Cellbion Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-14
First Submit QC Date:
None
Study First Post Date:
2025-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-24
Last Update Post Date Type:
ESTIMATED